Revised Heart Allocation Policy Improved Waitlist Mortality and Waiting Time With Maintained Outcomes in En-Bloc

Yasuhiro Shudo1, Hao He1, Stefan Elde1

  • 1Stanford Healthcare, Stanford, CA, United States.

Insights

The 2018 heart allocation policy update improved en-bloc heart-lung transplants. Patients experienced higher transplant rates, shorter wait times, and less waitlist mortality, with similar survival post-transplant.

Area of Science:

  • Cardiology
  • Transplant Surgery
  • Public Health Policy

Background:

  • The United Network for Organ Sharing (UNOS) revised its heart allocation policy in October 2018.
  • En-bloc heart-lung transplantation is a critical procedure for end-stage cardiopulmonary disease.

Purpose of the Study:

  • To evaluate the impact of the revised UNOS heart allocation policy on en-bloc heart-lung transplantation outcomes.
  • To compare transplant rates, waitlist mortality, and waiting times before and after the policy change.

Main Methods:

  • Analysis of a national transplant database.
  • Comparison of adult patients listed for en-bloc heart-lung transplants in pre- and post-policy implementation periods.
  • Evaluation of transplant rates, waitlist mortality, waiting times, life support utilization, ischemic times, transport distances, and short-term survival.

Main Results:

  • The post-policy period showed significantly higher transplant rates, shorter waiting times, and reduced waitlist mortality.
  • Increased utilization of life support (intra-aortic balloon pumps, ECMO, VADs) was observed in the post-period.
  • Transplant recipients in the post-period had longer ischemic times and transport distances but shorter waiting times.
  • Short-term survival rates were similar between the pre- and post-policy periods (p = 0.4357).

Conclusions:

  • The revised UNOS heart allocation policy significantly enhanced access to en-bloc heart-lung allografts.
  • The policy led to improved waitlist outcomes, including reduced mortality and shorter waiting times.
  • Post-transplant outcomes remained comparable, indicating a successful policy revision.